Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Agave Inulin in Metabolic Syndrome
NCT02773927Phase 3Completed
- Sponsor
- Centro Universitario de Ciencias de la Salud
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in metabolic syndrome (4 arms), sponsored by Centro Universitario de Ciencias de la Salud. Primary endpoint: Change from Baseline on adiponectin levels at 12 weeks. Started Jan 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02773927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773927.